首页> 美国卫生研究院文献>Nanomaterials >Loading of Indocyanine Green within Polydopamine-Coated Laponite Nanodisks for Targeted Cancer Photothermal and Photodynamic Therapy
【2h】

Loading of Indocyanine Green within Polydopamine-Coated Laponite Nanodisks for Targeted Cancer Photothermal and Photodynamic Therapy

机译:聚多巴胺涂层Laponite纳米磁盘中吲哚菁绿的负载量用于靶向癌症的光热和光动力疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The combination of photothermal therapy (PTT) and photodynamic therapy (PDT) in cancer treatment has attracted much attention in recent years. However, developing highly efficient and targeted therapeutic nanoagents for amplifying PTT and PDT treatments remains challenging. In this work, we developed a novel photothermal and photodynamic therapeutic nanoplatform for treatment of cancer cells overexpressing integrin αvβ3 through the coating of polydopamine (PDA) on indocyanine green (ICG)-loaded laponite (LAP) and then further conjugating polyethylene glycol-arginine-glycine-aspartic acid (PEG-RGD) as targeted agents on the surface. The ICG/LAP–PDA–PEG–RGD (ILPR) nanoparticles (NPs) formed could load ICG with a high encapsulation efficiency of 94.1%, improve the photostability of loaded ICG dramatically via the protection of PDA and LAP, and display excellent colloidal stability and biocompatibility due to the PEGylation. Under near-infrared (NIR) laser irradiation, the ILPR NPs could exert enhanced photothermal conversion reproducibly and generate reactive oxygen species (ROS) efficiently. More importantly, in vitro experiments proved that ILPR NPs could specifically target cancer cells overexpressing integrin αvβ3, enhance cellular uptake due to RGD-mediated targeting, and exert improved photothermal and photodynamic killing efficiency against targeted cells under NIR laser irradiation. Therefore, ILPR may be used as effective therapeutic nanoagents with enhanced photothermal conversion performance and ROS generating ability for targeted PTT and PDT treatment of cancer cells with integrin αvβ3 overexpressed.
机译:近年来,光热疗法(PTT)和光动力疗法(PDT)在癌症治疗中的结合引起了广泛的关注。然而,开发用于扩增PTT和PDT治疗的高效且靶向性的治疗纳米剂仍然具有挑战性。在这项工作中,我们开发了一种新型的光热和光动力学治疗性纳米平台,用于通过在载有吲哚花青绿(ICG)的合成锂皂石(LAP)上涂覆聚多巴胺(PDA),然后进一步偶联聚乙二醇-精氨酸-来过度表达整合素αvβ3的癌细胞。甘氨酸-天冬氨酸(PEG-RGD)作为表面上的靶向剂。形成的ICG / LAP–PDA–PEG–RGD(ILPR)纳米粒子(NPs)可以以94.1%的高封装效率负载ICG,通过保护PDA和LAP显着提高负载的ICG的光稳定性,并显示出优异的胶体稳定性由于聚乙二醇化而具有生物相容性。在近红外(NIR)激光照射下,ILPR NPs可再现地发挥增强的光热转化能力,并有效地产生活性氧(ROS)。更重要的是,体外实验证明ILPR NPs可以特异性靶向过度表达整联蛋白αvβ3的癌细胞,由于RGD介导的靶向作用而提高细胞摄取,并在NIR激光照射下对靶细胞发挥更好的光热和光动力杀伤效率。因此,ILPR可用作具有增强的光热转化性能和ROS产生能力的有效的治疗性纳米剂,用于靶向过表达整联蛋白αvβ3的癌细胞的靶向PTT和PDT治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号